The idea of Modern Medtech Park in Delhi germinates

Delhi’s Industry Minister sounded amenable, signals west Delhi as site

New Delhi: Modern Medical Device Manufacturing Cluster in Delhi may become a reality in foreseeable future. The Surgical Manufacturers & Traders Association (SMTA) gets a very positive nod from Industries Minister Sardar Manjinder Singh Sirsa in an event in Delhi. This will be godsend for manufacturing units in Lal Dora and unorganized slums.

Rajiv Nath, one of greatest champions of Make in India in Medical Device Domain, feels modern medtech park in Delhi is the need of the hour. Managing Director of Hindustan Syringes (HMD), a scintillating success story in syringe making, Mr Nath calling HMD a proud member of SMTA, is very optimistic about its prospect because of late he finds Union government very proactively promoting Make in India. Mr Nath, also forum coordinator of Association of Indian Medical Device Industry (AiMeD) not long ago, was prolific in praise for the government for ensuring level playing field for domestic medical device manufactures vis a vis foreign manufacturers.

Rajiv Nath in talk with Medicare News said, “Existing Delhi based medical devices units making surgical instruments, stethoscopes, or rehabilitation orthopaedic aids etc need to relocate n expand n b compliant to evolving regulatory requirements under MDR n pollution n factory Act norms for which a modern medical device cluster supporting infrastructure is needed as existence in Lal Dora n unorganised slums is threatened.”

Mr Nath further said, “The Industry Minister was kindly very empathetic to the needs n offered promptly pragmatic solutions- hopefully the idea of a Medtech Park in west Delhi will germinate into a tangible development in very near future to enable MakeinIndia n MakeinDelhi to stem the tide of UnmakeinDelhi n entrepreneurs being pushed out of Delhi”

Related Posts

NHS backs delayed‑release treatment for cystinosis

Decision expands options for eligible patients NHS England has recommended delayed‑release mercaptamine bitartrate for routine commissioning for eligible patients aged one year and above with nephropathic cystinosis. The decision provides…

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Mumbai/Pune: In a major regulatory enforcement action aimed at safeguarding public health, the Maharashtra Food and Drug Administration (FDA) has permanently cancelled the Ayurvedic drug manufacturing licence of Pune-based M/s Inducare Pharma…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

NHS backs delayed‑release treatment for cystinosis

NHS backs delayed‑release treatment for cystinosis

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

AmeriHealth Home Healthcare Celebrates 5 Years of Compassionate Care

AmeriHealth Home Healthcare Celebrates 5 Years of Compassionate Care